MGMaria Eugenia Gil-Pallares

Maria Eugenia Gil-Pallares

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Maria Eugenia Gil-Pallares has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Comparison of the IHC Expression of p16, p53, and MIB-1 in Extragenital Skin Bowenoid Lesions With High- and Low- Chronic Sun Damage

    by Pedro Gil-Pallares, Maria E. Gil-Pallares, Alba Navarro-Bielsa, Olalla Figueroa-Silva, Laura Taboada-Paz, José M. Suárez-Peñaranda

    Background: Bowen disease and bowenoid actinic keratosis are difficult to distinguish due to overlapping histopathology. This study evaluates the role of p16, p53, and MIB-1 staining patterns in differentiating high-chronic sun damage (H-CSD) and low-chronic sun damage bowenoid lesions. Methods: Sixty extragenital in situ squamous cell carcinomas were included. Lesions with elastosis were considered H-CSD. P16, p53, and MIB-1 staining patterns were classified as block, gradient, or focal. Results: Seventy-two percent of lesions were H-CSD. Full-thickness dysplasia was observed in all lesions, and basal layer involvement in 97%. P16 staining was positive in 80%, matching areas of higher atypia, with block pattern more frequent in H-CSD (58% vs. 47%, P = 0.047). P53 was positive in 47%, with block pattern more common in H-CSD (40% vs. 18%, P = 0.02). MIB-1 was positive in all cases. P16 and MIB-1 patterns coincided in 75%, independently of sun exposure. Conclusions: P16 and p53 expression may be less frequent in bowenoid lesions than previously described. Histopathological features like basal layer and adnexal or follicular involvement may not differentiate H-CSD from low-chronic sun damage lesions or Bowen disease from bowenoid actinic keratosis. Variations in p16, p53, and MIB-1 staining could indicate different dysplasia pathways, although further studies are needed to clarify their prognostic significance.


  • Breslow density ability to predict melanoma survival: should it be used in clinical practice?

    by Pedro Gil-Pallares, Olalla Figueroa-Silva, Laura Taboada-Paz, María Eugenia Gil-Pallares, María Dolores Sánchez-Aguilar Rojas, Vanesa Balboa-Barreiro, Alba Navarro-Bielsa, José Manuel Suárez-Peñaranda

    Background: Breslow density (BD) is an estimation of melanoma volume, which has emerged as a novel histopathological prognostic biomarker. Objectives: To evaluate the role of BD as a predictor of patients’ survival and assess its prognostic value in relation to overall survival (OS), disease-free survival (DFS), melanoma-specific survival (MSS) and metastasis-free survival (MFS). Methods: A retrospective observational study in a cohort of 107 patients with invasive melanoma was conducted. Kaplan–Meier and Log-rank tests were used for 10-year survival analysis. The ability of BD and Breslow thickness (BT) to predict survival was assessed using receiver operating characteristic curves. Results: The average follow-up was 115 months, excluding deaths. People with BD ≥ 65% showed lower survival rates compared with the BD < 65% group (log-rank test P < 0.001). Area under the curve (AUC) of BD ≥ 65% was higher than BTs for all studied survival rates except for MSS, in which absolute BD showed the highest value. Conclusions: BD is proposed as a simple, valuable and inexpensive histopathological feature that could provide additional valuable information to that available from melanoma staging, as it has proved to have a statistically significant prognostic value in relation to survival in patients with melanoma and comparable 10-year survival prediction ability with that of BT.

  • Tumour budding as a risk factor for lymph node metastases in cutaneous squamous cell carcinoma: a systematic review and meta-analysis

    by Pedro Gil-Pallares, Maria Eugenia Gil-Pallares, Alba Navarro-Bielsa, Olalla Figueroa-Silva, Laura Taboada-Paz, José Manuel Suárez-Peñaranda

    Background: Current staging systems have limitations in stratifying high-risk cutaneous squamous cell carcinoma (cSCC). Tumour budding (TB) has emerged as a potential prognostic factor in various cancers. Objectives: To evaluate the prognostic significance of TB in predicting lymph node metastases (NM) in cSCC. Methods: A comprehensive search of the PubMed, Web of Science, Embase and Cochrane databases was conducted. Studies investigating the association of TB using a 5-bud cutoff and NM in cSCC were included. A meta-analysis was performed using odds ratios (OR) to evaluate the association between TB and NM. Results: Six retrospective studies comprising 793 patients with cSCC were included. The random-effects analysis showed a significant association between high TB (≥ 5 buds) and NM (OR = 13.29, 95% confidence interval 5.55–31.86). Discussion: TB is a promising histopathological feature for predicting NM in cSCC. The results show a strong association between high TB and NM, supporting its utility as a risk factor for NM in cSCC. Its inclusion in clinical practice and cSCC staging might be helpful in the stratification of patients with high-risk cases and to guide optimal management strategies for each patient. However, further investigation is needed to determine standardized reporting guidelines for TB in cSCC.


  • Open Access

    O atraso no diagnóstico causado pelo lockdown da COVID‐19 piorou o prognóstico do melanoma?

    by Pedro Gil‐Pallares, Olalla Figueroa‐Silva, Maria Eugenia Gil‐Pallares, José Ángel Vázquez‐Bueno, Francisca Piñeyro‐Molina, Benigno Monteagudo, Cristina De Las Heras‐Sotos

  • Open Access

    Did COVID-19 lockdown delay actually worsen melanoma prognosis?

    by Pedro Gil-Pallares, Olalla Figueroa-Silva, Maria Eugenia Gil-Pallares, José Ángel Vázquez-Bueno, Francisca Piñeyro-Molina, Benigno Monteagudo, Cristina De Las Heras-Sotos